phylogica and university of queensland receive, page-5

Reading today's announcement, I believe this could very well be a disruptive technology, one which will truly be transformational.

Here's the passage that stood out for me...

The ultimate goal of the collaboration is the construction of a universal specificity Phylomer chip. This low-cost consumable device will allow the identification of peptide probes that are specific for any target biomolecule, in a matter of minutes. This goal has not been achieved with existing approaches (eg. antibody arrays) on a single chip due to the intrinsic biases that are inherent with existing classes of biologics based on one structural family (eg. the antibody variable region). Even comprehensive arrays of antibodies, peptides of random amino acid composition, or protein scaffolds, cannot be used reliably to detect any biological antigen due to this issue of structural bias.

I can truly appreciate the steps that were required to get to this stage of the development.

Moving forward...

* Low cost to develop chip.

* Peptide Chip product potentially on market in the not too distant future. They'll need to first construct then validate chip which could take a little while, but will be well worth the wait in my opinion.

* Then hand this over to Griffin Securities.

I understand why the CEO of Griffin Securities is claiming Phylogica's technology to be “a world-changing technology".

Tony